Citation only
via OpenAlex
Age-related macular degeneration therapy: a review
Michael J. Ammar, Jason Hsu, Allen Chiang, Allen C. Ho, Carl D. Regillo
Current Opinion in Ophthalmology · 2020 · ▲ 137 citations
Abstract
PURPOSE OF REVIEW: The purpose of this review is to describe the current clinical landscape of potential future therapies for both nonexudative (dry) and exudative (wet) age-related macular degeneration (AMD). We highlight some of the more promising treatments that are furthest along in development. RECENT FINDINGS: Patients with dry AMD have long been hoping for a highly efficacious treatment that may slow disease progression or even help regain vision. Patients with wet AMD have many effective treatment options but still there are those who have suboptimal responses or are burdened by the high frequency of treatment. We detail exciting new concepts and targets for novel medications. Specifically, for dry AMD we discuss research looking at complement inhibition, neuroprotection, visual cycle modulators, cell-based therapies, and anti-inflammatory agents. For wet AMD we summarize new, potentially more durable anti-vascular endothelial growth factor agents, extended release options, and gene therapy. SUMMARY: There are promising new strategies for AMD. Many of the potential new treatments are in or have recently completed phase 2 or phase 3 clinical trials with promising results thus far, including some that have received US Food and Drug Administration approval. Additional therapeutic breakthroughs will likely continue to occur thanks to the number of clinical trials that are nearing the finish line.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1097/icu.0000000000000657
- Canonical
- link ↗
- Fetched
- 2026-10-19 MST
Cite this
APA
Ammar, M.J., Hsu, J., Chiang, A., Ho, A.C., & Regillo, C.D. (2020). Age-related macular degeneration therapy: a review. <em>Current Opinion in Ophthalmology</em>. https://doi.org/10.1097/icu.0000000000000657
Vancouver
Ammar MJ, Hsu J, Chiang A, Ho AC, Regillo CD. Age-related macular degeneration therapy: a review. Current Opinion in Ophthalmology. 2020. doi:10.1097/icu.0000000000000657.
BibTeX
@article{michael2020Agerel,
title = {Age-related macular degeneration therapy: a review},
author = {Michael J. Ammar and Jason Hsu and Allen Chiang and Allen C. Ho and Carl D. Regillo},
journal = {Current Opinion in Ophthalmology},
year = {2020},
doi = {10.1097/icu.0000000000000657},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Developments in ophthalmology 2015
Citation only
Neovascular Age-Related Macular Degeneration
Retina 2012
Citation only
CURRENT KNOWLEDGE AND TRENDS IN AGE-RELATED MACULAR DEGENERATION
Expert Opinion on Pharmacotherapy 2008
Citation only
Pharmacotherapy of age-related macular degeneration
Current Opinion in Ophthalmology 2009
Citation only
Genetics of age-related macular degeneration
Current Opinion in Ophthalmology 2004
Citation only
Age-related macular degeneration and depression: a review of recent research
Oxidative Medicine and Cellular Longevity 2020
Open access · CC-BY